| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 109 / 151 | 28th | Q3 |
| Oncology | 319 / 428 | 25th | Q3 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical Advances in Hematology and Oncology
Clinical Advances in Hematology and Oncology is Scopus-indexed (Q3, CiteScore 1.3), WoS ESCI. Published by Millennium Medical Publishing, Inc..
Checked against the index lists dated .
ISSN 1543-0790Verify ISSN ↗
Publisher: Millennium Medical Publishing, Inc.
Cost to publish: No APC data — check the publisher
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Clinical Advances in Hematology and Oncology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2003–present, best quartile Q3, CiteScore 1.3.
What quartile is Clinical Advances in Hematology and Oncology in Scopus?
Clinical Advances in Hematology and Oncology is Q3 in Hematology (rank 109 of 151) and Q3 in Oncology (rank 319 of 428), by CiteScore 2025.
What is the impact factor of Clinical Advances in Hematology and Oncology?
Clinical Advances in Hematology and Oncology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.3, which places it in quartile Q3 at the 28th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.283, quartile Q3, with an H-index of 47.
Who publishes Clinical Advances in Hematology and Oncology and what is its ISSN?
Clinical Advances in Hematology and Oncology is published by Millennium Medical Publishing, Inc. Its ISSN is 1543-0790.
Is Clinical Advances in Hematology and Oncology in Web of Science?
Yes — indexed in the Emerging Sources Citation Index.
Is Clinical Advances in Hematology and Oncology open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Clinical Advances in Hematology and Oncology? — open metrics via OpenAlex
Clinical Advances in Hematology and Oncology has an h-index of 4 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 1.3, quartile Q3. On 2-year citations it ranks #140 of 148 Scopus journals in Hematology.
Clinical Advances in Hematology and Oncology published 5 papers in 2018; its busiest recent year was 2015 with 15. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for Clinical Advances in Hematology and Oncology? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.